Platelet Targeted Therapeutics

Platelet Targeted Therapeutics is a biotechnology company focused on developing novel gene and cell therapies for bleeding disorders. The company's core technology involves the targeted expression of therapeutic proteins, such as clotting factors, specifically within platelets to ensure localized delivery and protection from circulating inhibitors. This approach aims to provide a long-term cure for conditions like Hemophilia A and B by utilizing the platelet's natural role in hemostasis. By sequestering therapeutic proteins in alpha-granules, the platform potentially reduces the risk of immune system neutralization, a common challenge in traditional replacement therapies.